Fundraising FoxKB Investment — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Korean startup making biopolymer-based artificial organs for medical device testing and surgical training simulators.
Steve Park(Founder)in
Co-investorsAscendo VenturesDAYLI PartnersKorea Investment Partners
Idfy offers a trust infrastructure platform for identity verification and fraud prevention, providing an interconnected system aimed at stopping fraud at its source.
AI & Machine LearningCybersecurityFintechSaaS
Ashok Hariharan(Founder)inVineet Jawa(Founder)
Co-investorsElev8 Venture PartnersTenacity VenturesBlume VenturesNew Enterprise Associates (NEA)Trifecta Capital AdvisorsTransUnion
Pathalys Pharma is a biotechnology company developing and improving therapeutic treatments for patients with chronic kidney disease.
BiotechHealthtechResearch Triangle Park, US
BT Slingsby(Co-Founder & Executive Chairman)in
Co-investorsAbingworthCatalys PacificOrbiMedSamsara BioCapital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.